Deborah Arrindell is Executive Director/Therapeutic Area Head of Safety Oncology at Amgen.
She has been in the pharmaceutical industry since 2000 when she joined Roche Laboratories as Medical Director of Versed. Since that time Deborah has held various positions at Wyeth/Pfizer and Johnson and Johnson.
Deborah Arrindell attended Cornell University where she received a BS in biology. She then attended Yale University School of Medicine where she received her MD-MPH degree. Following two years of training in pediatrics, Deborah completed an anesthesiology and critical care training program at Johns Hopkins Hospital in Baltimore, Maryland. After spending a brief time in private practice anesthesia, Deborah returned to join the faculty at the Johns Hopkins Bayview Hospital as an Assistant Professor in Anesthesiology and Critical Care. During this time Deborah also obtained her law degree from the University Of Maryland School of Law. Deborah is admitted to the bar in New York, Maryland, and New Jersey.
My name's Deborah Arrindell. I'm the Class of '79. So when I was here I studied biology. I'm originally from Staten Island, New York. I can remember being here: genetics, five credits. So after Cornell, I ended up at Yale. So I always kind of knew I wanted to go to medical school. So that was ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
